Medtronic Introduces MiniMed™ Mio™ Advance Infusion Set Enabling Fewer Insertion Steps for People with Diabetes in the U.S.

AlixPartners Forecasts: Household Products Could Cost U.S. Manufacturers and Consumers 15% More This Year Due to Resin Shortage

While companies can’t control the market forces at play, they can take action to mitigate the risk and impact of supply chain disruption.

How To Control a Radio Frequency (RF) Process

The radio frequency welding and manufacturing process uses electromagnetic energy and pressure to fuse and permanently bond vinyl, thermoplastic, and coated materials to produce a specific product - all according to customer requirements. Using this RF sealing process, a distinct, one-piece perpetual bond is formulated that is both solid and resistant to ripping or tearing. But how is this process controlled, and with what specific tools? Read on.

Cartessa Aesthetics’ Innovative Multi-Modality Treatment Leads Demand for Non-Invasive Body Procedures

PHYSIQ is a novel, dual-modality system that offers deep heat to target tissue and electrical muscle stimulation (EMS) to re-educate muscle – all from one device and in one session.

Medtronic plc today introduced the MiniMed™ Mio™ Advance infusion set to all Medtronic insulin pump customers in the United States. The MiniMed Mio Advance infusion set is the newest addition to the MiniMed™ portfolio of infusion sets and gives people using insulin pumps an optimal user experience with fewer steps1.

The MiniMed Mio Advance infusion set is inserted in only four steps — individuals simply peel, pinch, place, and press to insert the infusion set.

The user-friendly design of the MiniMed Mio Advance infusion set enables:

  • One-handed insertion and flexibility to access more insertion sites1 on the body such as the lower back or back of the arm.
  • A fully hidden needle before, during, and after insertion.
  • Consistent insertion force with the built-in insertion device (called a “serter”).
  • Fewer insertion steps.
  • Rotation of sites for better skin health and insulin absorption1.

“Early feedback on the MiniMed Mio Advance infusion set has been fantastic,” said Krista Sugerman, vice president and general manager, Customer Retention and Experience for the Diabetes Group at Medtronic. “Our goal is to continuously improve and innovate core technologies to help people with diabetes continue to experience greater freedom and better health. We are excited to now make this infusion set available to more people and make the daily management of diabetes easier for our customers.”

Feedback from Medtronic Ambassadors using the MiniMed Mio Advance infusion set has been overwhelmingly positive:

“It was very easy to remove off of her body and it was not painful.” – Carlos, father of 13-year-old Medtronic insulin pump user

”The Mio Advance is easy to insert and pain free throughout the duration, I really like not having to carry a separate inserter.” – Mark, Medtronic insulin pump user

The MiniMed Mio Advance infusion set launched in select countries outside the U.S. in 2018 with 85% of patients preferring it to previous infusion sets2. MiniMed Mio Advance is manufactured by ConvaTec’s Unomedical subsidiary and is only available from Medtronic.



Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.